Pure Global

A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections - Trial NCT05614895

Access comprehensive clinical trial information for NCT05614895 through Pure Global AI's free database. This Phase 1 trial is sponsored by Hoffmann-La Roche and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 27 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05614895
Phase 1
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT05614895
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections
A Multicenter, Single-Dose, Uncontrolled, Open-label, One Group Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Patients With Bacterial Infections

Study Focus

Bacterial Infections

RO7223280

Interventional

drug

Sponsor & Location

Hoffmann-La Roche

Sarasota,Louisville,Royal Oak,Greenville,Portland,Lille,Limoges,Paris,Paris,Strasbourg,Jerusalem,Ramat-Gan,Tel Aviv,Seoul,Seoul,Chisinau, France,Israel,Moldova - Republic of,South Korea,United States of America

Timeline & Enrollment

Phase 1

Dec 03, 2022

Dec 26, 2023

27 participants

Primary Outcome

Plasma Concentrations of RO7223280

Summary

The main aim of the study is to investigate the plasma pharmacokinetics (PK) and safety of
 intravenous (IV) administration of a single dose of 600 mg RO7223280 in critically ill
 participants with bacterial infections.

ICD-10 Classifications

Bacterial infection, unspecified
Bacterial, viral and other infectious agents
Other bacterial intestinal infections
Other bacterial diseases
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT05614895

Non-Device Trial